Despite Profit Fallout, GSK Remains Optimist For 2031 Revenue Target Amidst Cancer Drug Sale Rise
GSK's oncology sales increased 98% in 2024, and reflects strong demand and potentially new launches or indications for cancer therapies.
Arizona Daily Star42m
Arizona sues maker of asthma inhaler over pricing 'scheme'
PHOENIX — Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to increase ...